CL

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2026 third quarter earnings conference call on Friday, October 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Executive Vice President, Investor Relations, Claire Ross. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colg.

Some of the most boring products in your grocery cart have quietly funded dividend streaks stretching back decades, and five companies selling those exact staples are still raising payouts even as their own businesses face serious headwinds.

Colgate-Palmolive has paid a dividend since 1895 and has 63 years of consecutive dividend growth. To collect around $1,000 in dividend income annually from a Colgate-Palmolive stock purchase, a $43,239 investment would be required.

CL's fundamentals are supported by global diversification, emerging-market growth and Hill's strength, while CLX leans on recovery and GOJO.

CL's innovation, premiumization and emerging-market expansion are strengthening its brands and creating avenues for long-term growth.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either National Vision (EYE) or Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Fluoride-free, anti-sensitivity toothpaste — formulated with naturally derived Calcium Carbonate and Arginine — for whitening and sensitivity relief KENNEBUNK, Maine, Sept. 23, 2026 /PRNewswire/ -- As more consumers seek trusted fluoride-free oral care, Tom's of Maine is expanding its natural care portfolio with Hydroxyapatite Toothpaste, an anti-sensitivity toothpaste with naturally derived Arginine and Calcium Carbonate.

Procter & Gamble and Colgate differ in portfolio breadth, category leadership, premiumization and digital investment as they defend consumer staples share.

Two Dividend Kings with 50-plus years of consecutive raises have reported earnings, and one of them is funding its payout in a way that should raise eyebrows. The question is whether that really makes it the riskier bet.